Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC()

Advances in molecular analyses based on high-throughput technologies can contribute to a more accurate classification of non–small cell lung cancer (NSCLC), as well as a better prediction of both the disease course and the efficacy of targeted therapies. Here we set out to analyze whether global gen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Oncol
Hlavní autoři: Charkiewicz, Radoslaw, Niklinski, Jacek, Claesen, Jürgen, Sulewska, Anetta, Kozlowski, Miroslaw, Michalska-Falkowska, Anna, Reszec, Joanna, Moniuszko, Marcin, Naumnik, Wojciech, Niklinska, Wieslawa
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press 2017
Témata:
Original article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408153/
https://ncbi.nlm.nih.gov/pubmed/28456114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.01.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky